Primaquine - Revision history

Danbot: Restore original dosing content alongside dynamic SMW tables

2026-03-20T02:39:03Z

Restore original dosing content alongside dynamic SMW tables

← Revisión anterior		Revisión del 02:39 20 mar 2026
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
			*[[PCP pneumonia]], HIV+ : 15-30mg PO daily with clindamycin
			*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent
			*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Adult]]		{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Adult]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

	==Pediatric Dosing==		==Pediatric Dosing==
			*[[Malaria]] treatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent
			*[[Malaria]] prophylaxis: 0.8 mg/kg PO daily (max 52.6mg daily) starting 1-2 days prior to arrival in endemic area until 7-14 days after departure


	===Indications by Disease===		===Indications by Disease===
	{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Pediatric]]		{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Pediatric]]
	\|?Treats disease=Disease		\|?Treats disease=Disease
	\|?Has Dose=Dose		\|?Has Dose=Dose
	\|?Has Context=Context		\|?Has Context=Context
	\|format=table		\|format=table
	\|limit=50		\|limit=50
	\|mainlabel=-		\|mainlabel=-
	\|headers=show		\|headers=show
	\|sort=Treats disease		\|sort=Treats disease
	}}		}}

Danbot: Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

2026-03-20T01:53:41Z

Replace manual dosing with dynamic SMW tables (Adult + Pediatric)

← Revisión anterior		Revisión del 01:53 20 mar 2026
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	*[[~~PCP pneumonia~~]]~~, HIV+ : 15-30mg PO daily with clindamycin~~		===Indications by Disease===
	*[[~~Malaria~~]] ~~treatment: 26.3~~-~~52.6mg PO daily in combination with an additional anti-malarial agent~~		{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Adult]]
	*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure		\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Pediatric Dosing==		==Pediatric Dosing==
	*[[~~Malaria~~]] ~~treatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent~~		===Indications by Disease===
	*[[~~Malaria~~]] ~~prophylaxis: 0.8 mg/kg PO daily (max 52.6mg daily) starting 1~~-~~2 days prior to arrival in endemic area until 7-14 days after departure~~		{{#ask: [[Has DrugName::Primaquine]] [[Has Population::Pediatric]]
			\|?Treats disease=Disease
			\|?Has Dose=Dose
			\|?Has Context=Context
			\|format=table
			\|limit=50
			\|mainlabel=-
			\|headers=show
			\|sort=Treats disease
			}}

	==Special Populations==		==Special Populations==

ClaireLewis at 21:57, 23 September 2019

2019-09-23T21:57:48Z

← Revisión anterior		Revisión del 21:57 23 sep 2019
Línea 1:		Línea 1:
	==Administration==		==Administration==
	*Type: ~~Anti-malarial~~, anti-PCP		*Type: [[Antimalarial]], anti-[[PCP]]
	*Dosage Forms:		*Dosage Forms:
	*Routes of Administration: oral		*Routes of Administration: oral
Línea 48:		Línea 48:
	<references/>		<references/>
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
			[[Category:ID]]

Mholtz: Text replacement - "* " to "*"

2017-07-24T01:12:36Z

Text replacement - "* " to "*"

← Revisión anterior		Revisión del 01:12 24 jul 2017
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	* [[PCP pneumonia]], HIV+ : 15-30mg PO daily with clindamycin		*[[PCP pneumonia]], HIV+ : 15-30mg PO daily with clindamycin
	*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent		*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent
	*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure		*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure

ClaireLewis: /* Adult Dosing */

2016-11-07T21:10:03Z

Adult Dosing

← Revisión anterior		Revisión del 21:10 7 nov 2016
Línea 6:		Línea 6:

	==Adult Dosing==		==Adult Dosing==
	* [[~~Pneumocystis~~ pneumonia]], HIV+ : 15-30mg PO daily with clindamycin		* [[PCP pneumonia]], HIV+ : 15-30mg PO daily with clindamycin
	*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent		*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent
	*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure		*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure

	==Pediatric Dosing==		==Pediatric Dosing==
	*[[Malaria]] treatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent		*[[Malaria]] treatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent

ClaireLewis: Created page with "==Administration== Type: Anti-malarial, anti-PCP Dosage Forms: Routes of Administration: oral Common Trade Names: ==Adult Dosing== * Pneumocystis pneumonia, HIV+ : 1..."

2016-11-07T21:09:46Z

Created page with "==Administration== *Type: Anti-malarial, anti-PCP *Dosage Forms: *Routes of Administration: oral *Common Trade Names: ==Adult Dosing== * Pneumocystis pneumonia, HIV+ : 1..."

Página nueva

==Administration==
*Type: Anti-malarial, anti-PCP
*Dosage Forms:
*Routes of Administration: oral
*Common Trade Names:

==Adult Dosing==
* [[Pneumocystis pneumonia]], HIV+ : 15-30mg PO daily with clindamycin
*[[Malaria]] treatment: 26.3-52.6mg PO daily in combination with an additional anti-malarial agent
*[[Malaria]] prophylaxis: 52.6mg PO daily starting 1-2 days prior to arrival in endemic area until 7-14 days after departure
==Pediatric Dosing==
*[[Malaria]] treatment: 0.8 mg/kg PO daily (max 52.6mg daily) in combination with an additional anti-malarial agent
*[[Malaria]] prophylaxis: 0.8 mg/kg PO daily (max 52.6mg daily) starting 1-2 days prior to arrival in endemic area until 7-14 days after departure

==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: D
*[[Lactation risk categories|Lactation risk]]: Infant risk cannot be ruled out
*Renal dosing:
*Hepatic dosing:

==Contraindications==
*Allergy to class/drug
*Concomitant use with other potentially hemolytic or myeloid suppressing drugs
*Acutely ill patients with diseases prone to granulocytopenia (e.g. SLE or rheumatoid arthritis)

==Adverse Reactions==
===Serious===
*Hemolytic anemia, leukopenia
*Methemoglobinemia
===Common===
*Nausea, abdominal pain

==Pharmacology==
*Half-life: 4-7 hours
*Metabolism:
*Excretion:

==Mechanism of Action==
*Eliminates tissue infection, thus preventing erythrocytic forms of parasite

==Comments==

==See Also==
*[[Malaria]]

==References==
<references/>
[[Category:Pharmacology]]